According to Mesa Laboratories's latest financial reports the company's total debt is $0.23 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-03-31 | $0.18 B | -15.82% |
2022-03-31 | $0.22 B | 50.74% |
2021-03-31 | $0.14 B | 3.77% |
2020-03-31 | $0.14 B | 521.75% |
2019-03-31 | $22.73 M | -50.85% |
2018-03-31 | $46.26 M | -15.58% |
2017-03-31 | $54.8 M | 21.1% |
2016-03-31 | $45.25 M | 72.38% |
2015-03-31 | $26.25 M | 59.09% |
2014-03-31 | $16.5 M | 312.5% |
2013-03-31 | $4 M | |
2011-03-31 | $6.5 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $34.91 B | 14,689.07% | ๐บ๐ธ USA |
Ametek AME | $3.37 B | 1,329.22% | ๐บ๐ธ USA |
General Electric GE | $22.93 B | 9,614.95% | ๐บ๐ธ USA |
Danaher DHR | $19.53 B | 8,174.46% | ๐บ๐ธ USA |
3M MMM | $16.85 B | 7,038.50% | ๐บ๐ธ USA |
Steris STE | $3.50 B | 1,386.26% | ๐ฎ๐ช Ireland |
Rockwell Medical
RMTI | $14.87 M | -93.70% | ๐บ๐ธ USA |
Bruker BRKR | $1.37 B | 484.33% | ๐บ๐ธ USA |
AngioDynamics ANGO | $4.72 M | -98.00% | ๐บ๐ธ USA |